Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic Plasma Transfusion for Invasive Procedures
NCT02637427Phase 3Completed
- Sponsor
- Rutgers University
- Start
- Feb 2016
- Primary completion
- Jun 2019
- Modality
- Recombinant Proteins and Enzymes, Tissue Cells
- Countries
- 1
01
Overview
Phase 3, randomised trial of fresh-frozen plasma in hemorrhage (2 arms), sponsored by Rutgers University. Primary endpoint: Change in Hemoglobin Level. Started Feb 2016; status: completed.
02
Drugs
fresh-frozen plasma
03
Conditions
hemorrhage
Beyond the preview
Go deeper on NCT02637427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02637427.